市場調查報告書
商品編碼
1466061
封閉式系統輸送設備市場:按組件、類型、封閉機制、技術、可用性、最終用途 - 2024-2030 年全球預測Closed System Transfer Devices Market by Component (Bag Access Devices, Syringe Safety Devices, Vial Access Devices), Type (Membrane to Membrane Systems, Needleless Systems), Closing Mechanism, Technology, Usability, End-Use - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年封閉式系統輸送設備市場規模為11.8億美元,預計2024年將達到13.2億美元,2030年將達到26.6億美元,複合年成長率為12.31%。
封閉式系統輸送裝置 (CSTD) 旨在安全地將藥物從一個儲存器轉移到另一個儲存器,同時降低醫護人員、病患和環境接觸潛在危險藥物或蒸氣的風險。這些設備對於處理有毒物質至關重要,特別是在進行化療和其他有害物質的醫院和醫療機構。 CSTD 市場的成長是由職業安全意識的提高、危險藥物處理的嚴格規定以及需要化療的癌症盛行率的上升所推動的。然而,與實施 CSTD 相關的高成本可能會構成巨大障礙,特別是對於預算限制更為明顯的發展中地區的醫療機構。此外,某些設備的複雜性可能需要對醫療保健專業人員進行廣泛的培訓,從而進一步影響普及。 CSTD 市場的機會因素包括技術進步和創新,從而開發出更有效率、更方便用戶使用且更具成本效益的設備。此外,全球不斷擴展的腫瘤學領域為 CSTD 的採用提供了絕佳的機會,因為化療藥物的安全處理至關重要。世界各地加強醫療機構職場安全標準的努力也進一步支持了市場成長前景,凸顯了 CSTD 在現代醫療機構中的重要性。
主要市場統計 | |
---|---|
基準年[2023] | 11.8億美元 |
預測年份 [2024] | 13.2億美元 |
預測年份 [2030] | 26.6億美元 |
複合年成長率(%) | 12.31% |
元件袋存取裝置的使用激增,以降低溢出和霧化的風險
袋接取裝置設計用於牢固地連接至靜脈注射 (IV) 袋。其主要作用是將液體藥物和溶液安全地轉移到靜脈輸液袋中,而不會使醫護人員或周圍環境接觸到藥物。當使用與皮膚接觸或吸入可能有害的藥物時,這一點尤其重要。袋子存取裝置具有防漏和氣密機制,可確保藥物包含在系統內,從而降低藥物溢出和霧化的風險。注射器安全裝置旨在防止醫療保健專業人員將藥物注射到注射器或給患者服用時可能發生的針刺傷害。這些設備配有安全機制,例如防護罩和可伸縮針頭,可自動或手動啟動。一旦啟動,該機構就會覆蓋針頭,大大降低意外針刺傷的風險。這可以保護醫護人員並防止血液傳播疾病的潛在傳播。管瓶存取裝置用於安全地從小管瓶取出藥物。管瓶接入裝置確保管瓶和注射器或其他封閉式系統輸送裝置部件之間的密封連接。與袋子存取裝置類似,它們旨在透過提供氣密、無洩漏的傳輸來防止接觸危險藥物。這些裝置通常包括刺穿管瓶橡膠塞的針或尖頭,以安全地取出藥物,而無需將管瓶打開到外部環境。
最終用途:擴大封閉式系統運輸設備在腫瘤診所和腫瘤中心的使用
醫院是CSTD廣泛使用的主要環境之一。醫院藥品處理流程多元、量大,需要嚴格的安全措施。 CSTD 在保護醫護人員免於接觸潛在有害藥物化合物方面發揮重要作用。在醫院中,CSTD 的使用涉及多個部門,包括藥房、腫瘤病房和加護病房。腫瘤診所和中心專門從事癌症治療,廣泛使用化療藥物。鑑於化療的強效性質以及接觸化療藥物可能對健康產生不良影響的可能性,在這些環境中使用 CSTD 對於醫護人員和患者的健康至關重要。
區域洞察
在美洲,醫療機構對安全協議(包括 CSTD 的使用)的認知和實施程度很高。這得到了強力的政府法規的支持,例如美國藥典 (USP) 指南,該指南要求在處理危險藥物時使用 CSTD。由於強大的資金籌措和研究舉措,該地區是 CSTD 市場製造和不斷創新的幾家重要公司的所在地。在亞太地區,CSTD 的採用率正在穩步增加,這主要是由於意識的提高和醫療保健法規的逐步收緊。日本、中國和澳洲等國家處於前線,各國政府支持更安全的藥品處理。然而,政府的支持和監管程度不如美洲全面。歐洲國家展現了對醫護人員安全的堅定承諾,一些國家採用了推薦或強制執行 CSTD 的指南。這包括歐盟(EU)的積極支持。然而,在中東和非洲,儘管政府支持和認知程度各異,但科學技術發展委員會的實施仍處於相對早期階段。歐洲、中東和非洲地區的 CSTD 生產和供應主要由歐洲公司推動,但尋求擴展到這些市場的國際公司也越來越多。
FPNV定位矩陣
FPNV定位矩陣對於評估封閉式系統運輸設備市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對封閉式系統輸送設備市場中供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4. 競爭評估和情報:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.封閉式系統輸送設備市場的市場規模與預測為何?
2.在封閉式系統輸送設備市場的預測期間內,有哪些產品、細分市場、應用和領域需要考慮投資?
3.封閉式系統輸送設備市場的技術趨勢與法規結構是什麼?
4.封閉式系統輸送設備市場主要廠商的市場佔有率為何?
5.進入封閉式系統運輸設備市場的適當型態和策略性手段是什麼?
[195 Pages Report] The Closed System Transfer Devices Market size was estimated at USD 1.18 billion in 2023 and expected to reach USD 1.32 billion in 2024, at a CAGR 12.31% to reach USD 2.66 billion by 2030.
Closed system transfer devices (CSTDs) are designed to safely transfer medication from one reservoir to another while lowering the risk of exposure to potentially hazardous drugs or vapors to healthcare workers, patients, and the environment. These devices are integral in handling toxic substances, particularly in hospitals and healthcare settings where chemotherapy agents and other hazardous drugs are administered. The growth of the CSTD market is propelled by increasing awareness about occupational safety, stringent regulations for handling hazardous drugs, and the rising prevalence of cancer, necessitating chemotherapy treatments. However, high costs associated with adopting CSTDs can be a substaintial barrier for healthcare facilities, particularly in developing regions with more pronounced budget constraints. Additionally, the complexity of some devices may require extensive training for healthcare professionals, further impacting their widespread adoption. Opportunistic factors for the CSTD market include technological advancements and innovation, which can lead to more efficient, user-friendly, and cost-effective devices. Moreover, the expanding oncology sector worldwide presents significant opportunities for adopting CSTDs, given the critical need for safely handling chemotherapy drugs. The ongoing efforts to enhance workplace safety standards in healthcare settings across the globe further bolster the market's growth prospects, underscoring the importance of CSTDs in modern medical practices.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 1.18 billion |
Estimated Year [2024] | USD 1.32 billion |
Forecast Year [2030] | USD 2.66 billion |
CAGR (%) | 12.31% |
Component: Burgeoning use of bag access devices reduces the risk of spills or aerosolization
Bag access devices are designed to securely connect to intravenous (IV) bags. Their primary role is to safely transfer liquid medications or solutions into the IV bags without exposing healthcare workers or the surrounding environment to the medication. This is particularly important when handling medications that can be harmful if they come into contact with skin or are inhaled. Bag access devices employ a leak-proof and airtight mechanism to ensure the medication is contained within the system, reducing the risk of spills or aerosolization. Syringe safety devices are engineered to prevent needle-stick injuries, which can occur when healthcare professionals are drawing medication into a syringe or administering it to a patient. These devices come with a safety mechanism, such as a shield or a retractable needle, that activates automatically or manually. Once activated, the mechanism covers the needle, significantly reducing the risk of accidental needle-stick injuries. This protects healthcare workers and helps prevent the potential transmission of blood-borne diseases. Vial access devices are used to withdraw medication from vials safely. They ensure a sealed connection between the vial and the syringe or another closed system transfer device component. Like bag access devices, they aim to prevent exposure to hazardous drugs by providing an airtight and leak-proof transfer. These devices often come with a needle or a spike that pierces the vial's rubber stopper, allowing for safe medication withdrawal without opening the vial to the external environment.
End-Use: Evolving utilization of closed system transfer devices in oncology clinics & oncology centers
Hospitals constitute one of the primary settings where CSTDs are extensively used. The diverse and high-volume nature of drug-handling processes in hospitals necessitates stringent safety measures. CSTDs play a crucial role in protecting healthcare personnel from exposure to potentially harmful drug compounds. In a hospital setting, the utilization of CSTDs spans several departments, including pharmacies, oncology wards, and intensive care units. Oncology clinics and centers specialize in cancer treatment, where chemotherapy drugs are prevalent. Given the potent nature of chemotherapy agents and their potential adverse health effects upon exposure, employing CSTDs in these settings is crucial for the well-being of both healthcare workers and patients.
Regional Insights
In the Americas, there is a high awareness of and implementation of safety protocols in healthcare settings, including using CSTDs. Strong government regulations, such as the United States Pharmacopeia (USP) Chapter guidelines, bolstered this, which mandate using CSTDs when handling hazardous drugs. The region hosts several significant companies that manufacture and constantly innovate in the CSTD market, owing to robust funding and research initiatives. In the APAC region, the adoption of CSTDs is growing steadily, primarily driven by increasing awareness and gradually strengthening healthcare regulations. Countries such as Japan, China, and Australia are at the forefront, with governments supporting safer drug-handling practices. However, the level of government support and regulation is less comprehensive than in the Americas. European countries have shown a strong commitment to healthcare worker safety, with several nations incorporating guidelines recommending or mandating CSTDs. This has been coupled with active support from the European Union in some cases. However, the Middle East and Africa are still in the relatively early stages of adopting these devices, with varying degrees of government support and awareness. The production and availability of CSTDs in the EMEA region are primarily driven by European companies, with a growing presence of international firms looking to expand into these markets.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Closed System Transfer Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Closed System Transfer Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Closed System Transfer Devices Market, highlighting leading vendors and their innovative profiles. These include B. Braun AG, Baxter International Inc., Becton, Dickinson and Company, Caragen Limited, Cardinal Health, Inc., Epic Medical, Equashield LLC, Fresenius Kabi, ICU Medical, Inc., JMS Co., Ltd., Medline Industries, LP, Meissner Corporation, Nipro Corporation, Paragon Care Limited, Sartorius AG, Simplivia Healthcare Ltd., Vygon (UK) Ltd, and Yukon Medical, LLC.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Closed System Transfer Devices Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Closed System Transfer Devices Market?
3. What are the technology trends and regulatory frameworks in the Closed System Transfer Devices Market?
4. What is the market share of the leading vendors in the Closed System Transfer Devices Market?
5. Which modes and strategic moves are suitable for entering the Closed System Transfer Devices Market?